Published on 12 May 2024 on Simply Wall St. via Yahoo Finance
Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights
Guardant Health's estimated fair value is US$39.63 based on 2 Stage Free Cash Flow to EquityCurrent share price of US$22.37 suggests Guardant Health is potentially 44% undervalued The US$38.94 analyst price target for GH is 1.7% less than our estimate of fair value
In this article we are going to estimate the intrinsic value of Guardant Health, Inc. (NASDAQ:GH) by taking the forecast future cash flows of the company and discounting them back to today's value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Believe it or not, it's not too difficult to follow, as you'll see from our example!